[The significance of local fibrinolysis increase in symptomatic hematuria and its inhibition by p-aminomethylbenzoic acid].
D000328:Adult; D000368:Aged; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D003864:Depression, Chemical; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects*; D006417:Hematuria / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011468:Prostatectomy; D001749:Urinary Bladder Neoplasms / Q000150:complications; D014556:Urine / Q000382:microbiology; D014570:Urologic Diseases / Q000150:complications
D000933:Antifibrinolytic Agents; D001565:Benzoates
Die Bedeutung lokaler Fibrinolysesteigerungen bei der symptomatischen Hämaturie und ihre Hemmung durch p-Aminomethylbenzoesäure.